JOHANNSEN, B., Michal KARPÍŠEK, D. BAUMGARTNER, V. KLEIN, N. BOSTANCI, N. PAUST, S.M. FRUEH, R. ZENGERLE a K. MITSAKAKIS. One-step, wash-free, bead-based immunoassay employing bound-free phase detection. Analytica Chimica Acta. Amsterdam: Elsevier, 2021, roč. 1153, č. 1, s. 1-9. ISSN 0003-2670. Dostupné z: https://dx.doi.org/10.1016/j.aca.2021.338280.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název One-step, wash-free, bead-based immunoassay employing bound-free phase detection.
Autoři JOHANNSEN, B. (garant), Michal KARPÍŠEK (203 Česká republika, domácí), D. BAUMGARTNER, V. KLEIN, N. BOSTANCI, N. PAUST, S.M. FRUEH, R. ZENGERLE a K. MITSAKAKIS.
Vydání Analytica Chimica Acta, Amsterdam, Elsevier, 2021, 0003-2670.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 6.911
Kód RIV RIV/00216224:14160/21:00122556
Organizační jednotka Farmaceutická fakulta
Doi http://dx.doi.org/10.1016/j.aca.2021.338280
UT WoS 000635606500009
Klíčová slova anglicky Bound-free phase; Immunoassay; Inflammation; Micro/nanoparticles; Oral biomarkers; Saliva
Štítky rivok, ÚFTo
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: JUDr. Sabina Krejčiříková, učo 383857. Změněno: 14. 4. 2022 14:06.
Anotace
We present a simple and fast one-step heterogeneous immunoassay, with performance characteristics that can enable easy and versatile adaptation to miniaturized, automated point-of-care systems. This novel analytical method uses magnetic and fluorescent beads as capture and detection agents respectively. Its main feature is the measurement of the fluorescent signal in the bound-free phase for (semi-)quantitative detection of analytes. Thus, no washing is required and the workflow consists only of sample and reagent supply, incubation, separation and detection. The immunoassay concept is demonstrated with C-reactive protein (CRP), a systemic inflammation marker. CRP in only 5 μL of undiluted serum was measured in the range 20-140 mg L-1 (includes clinically relevant cut-off values). The limit of detection (LOD) was 22.1 ± 6.3 mg L-1 (incubation 15 min). A CRP certified reference material was measured on five different days. Intra- and inter-assay coefficients of variation were 4.6 ± 1.9% and 5.6% respectively. To demonstrate the compatibility of the assay concept with additional matrices and concentration ranges, three oral inflammation markers, namely matrix metalloproteinases 8 and 9 (MMP-8, MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1), were measured in saliva in the ranges 0.47-30 ng mL-1 for MMP-8 and MMP-9, and 0.69-44 ng mL-1 for TIMP-1. LODs were 0.24 ng mL-1, 0.38 ng mL-1 and 0.39 ng mL-1 respectively (incubation 20 min). Multiplexing capacity of the assay concept was also shown with these markers. The demonstrated excellent reproducibility of the results, combined with the versatility and low complexity of the introduced immunoassay concept, make it an attractive candidate for applied analytical chemistry and automated point-of-care testing.
VytisknoutZobrazeno: 12. 5. 2024 23:09